SciTech Development
Advancing Cancer Treatment Through Safer Drug Delivery
Overview
Raised: $137,288
Rolling Commitments ($USD)
07/30/2022
$1,009
101
2000
Healthcare & Pharmaceuticals
Biotech
B2B
Medium
High
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-357,642 |
$-276,167 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$133,834 |
$370,223 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$327,348 |
$493,530 |
Short-Term Debt |
$0 |
$0 |
Long-Term Debt |
$1,567,867 |
$1,360,186 |
Total Liabilities |
$1,567,867 |
$1,360,186 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual